Immune Biosolutions (IBio) is an innovative biotech company focused on the discovery and engineering of chicken edible and recombinant antibodies with a recognized, yet unexploited, therapeutic potential. Our focus is to change the odds of antibody discovery against traditionally difficult target, such as GPCRs and other membranes proteins.